Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan

Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan

Abstract Background Early-stage colorectal cancer had excellent outcomes after curative resection, typically. However, a perplexing survival paradox between stage II and stage III was noted. This paradox could be influenced by the administration of routine postoperative adjuvant chemotherapy and the...

Full description

Bibliographic Details
Main Authors: Yen-Lin Yu, Wen-Ko Tseng, Chun-Kai Liao, Chien-Yuh Yeh, Hong-Hwa Chen, Yu-Hsuan Liu, Yu-Wei Liaw, Chung-Wei Fan
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Cancer
Subjects:
Stage II colorectal cancer
Tegafur/uracil (UFT)
Adjuvant chemotherapy
Online Access:https://doi.org/10.1186/s12885-023-11310-6

Similar Items

Similar Items